These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 21684731

  • 1. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease.
    Dalal AA, Shah M, Lunacsek O, Hanania NA.
    Respir Med; 2011 Oct; 105(10):1516-22. PubMed ID: 21684731
    [Abstract] [Full Text] [Related]

  • 2. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM, Akazawa M, Dalal A, Simoni-Wastila L.
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [Abstract] [Full Text] [Related]

  • 3. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L, Blanchette CM, Qian J, Yang HW, Zhao L, Zuckerman IH, Pak GH, Silver H, Dalal AA.
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [Abstract] [Full Text] [Related]

  • 4. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J, Boulanger L, Marton J, Guadagno L, Dastani H, Dirani R, Phillips A, Shah H.
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [Abstract] [Full Text] [Related]

  • 5. Comparison of hospitalizations, emergency department visits, and costs in a historical cohort of Texas Medicaid patients with chronic obstructive pulmonary disease, by initial medication regimen.
    Rascati KL, Akazawa M, Johnsrud M, Stanford RH, Blanchette CM.
    Clin Ther; 2007 Jun; 29(6):1203-13. PubMed ID: 17692734
    [Abstract] [Full Text] [Related]

  • 6. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K, Targowski T, From S.
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [Abstract] [Full Text] [Related]

  • 7. Medical care costs among patients with established cardiovascular disease.
    Nichols GA, Bell TJ, Pedula KL, O'Keeffe-Rosetti M.
    Am J Manag Care; 2010 Mar; 16(3):e86-e93. PubMed ID: 20205493
    [Abstract] [Full Text] [Related]

  • 8. Economic burden of chronic obstructive pulmonary disease.
    Teo WS, Tan WS, Chong WF, Abisheganaden J, Lew YJ, Lim TK, Heng BH.
    Respirology; 2012 Jan; 17(1):120-6. PubMed ID: 21954985
    [Abstract] [Full Text] [Related]

  • 9. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD.
    Lin PJ, Shaya FT, Scharf SM.
    Respir Med; 2010 May; 104(5):697-704. PubMed ID: 19954941
    [Abstract] [Full Text] [Related]

  • 10. Comparison of health care costs and co-morbidities between men diagnosed with benign prostatic hyperplasia and cardiovascular disease (CVD) and men with CVD alone in a US commercial population.
    Shah M, Butler M, Bramley T, Curtice TG, Fine S.
    Curr Med Res Opin; 2007 Feb; 23(2):417-26. PubMed ID: 17288695
    [Abstract] [Full Text] [Related]

  • 11. Rehospitalization risks and outcomes in COPD patients receiving maintenance pharmacotherapy.
    Dalal AA, Shah M, D'Souza AO, Crater GD.
    Respir Med; 2012 Jun; 106(6):829-37. PubMed ID: 22425138
    [Abstract] [Full Text] [Related]

  • 12. Economic burden prior to COPD diagnosis: a matched case-control study in the United States.
    Akazawa M, Halpern R, Riedel AA, Stanford RH, Dalal A, Blanchette CM.
    Respir Med; 2008 Dec; 102(12):1744-52. PubMed ID: 18760581
    [Abstract] [Full Text] [Related]

  • 13. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
    Gerhardsson de Verdier M, Andersson M, Kern DM, Zhou S, Tunceli O.
    Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
    [Abstract] [Full Text] [Related]

  • 14. Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD.
    Yu AP, Guérin A, de Leon DP, Ramakrishnan K, Wu EQ, Mocarski M, Blum SI, Setyawan J.
    Respir Med; 2011 Dec; 105(12):1861-71. PubMed ID: 21807487
    [Abstract] [Full Text] [Related]

  • 15. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes.
    Mody R, Kalsekar I, Kavookjian J, Iyer S, Rajagopalan R, Pawar V.
    J Diabetes Complications; 2007 Dec; 21(2):75-83. PubMed ID: 17331855
    [Abstract] [Full Text] [Related]

  • 16. Economic assessment of early initiation of inhaled corticosteroids in chronic obstructive pulmonary disease using propensity score matching.
    Akazawa M, Biddle AK, Stearns SC.
    Clin Ther; 2008 Dec; 30 Spec No():1003-16. PubMed ID: 18640475
    [Abstract] [Full Text] [Related]

  • 17. Cost and utilization of COPD and asthma among insured adults in the US.
    Blanchette CM, Broder M, Ory C, Chang E, Akazawa M, Dalal AA.
    Curr Med Res Opin; 2009 Jun; 25(6):1385-92. PubMed ID: 19419342
    [Abstract] [Full Text] [Related]

  • 18. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
    Joyce AT, Smith P, Khandker R, Melin JM, Singh A.
    J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658
    [Abstract] [Full Text] [Related]

  • 19. [Analysis on direct economic burden of community COPD patients and its influence factors in Chengdu].
    Zhang B, Zhang Y, Yang J, Liu X.
    Wei Sheng Yan Jiu; 2007 Nov; 36(6):706-10. PubMed ID: 18303632
    [Abstract] [Full Text] [Related]

  • 20. [Costs of chronic obstructive pulmonary disease in patients treated in ambulatory care in Poland].
    Jahnz-Różyk K, Targowski T, From S, Faluta T, Borowiec L.
    Pneumonol Alergol Pol; 2011 Nov; 79(5):337-42. PubMed ID: 21861257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.